Marina Milan

Company: FNIH

Job title: Project Manager

Seminars:

Defining Tumor & Immune Markers to Stratify Patients at Risk of Developing Multiple Myeloma from MGUS & Smoldering Myeloma 3:30 pm

It is feasible of developing biomarkers from liquid biopsies in ALL and AML as evidenced from 2 projects in hematologic conditions MRD can be used as a prognostic indicator. Efforts are underway to develop biomarkers for progression from MGUS to Multiple Myeloma Inclusion of patient advocacy groups and patients with lived experience provides valuable insight…Read more

day: Conference Day 1